Evidence map›Paper›PMID 18245817›Full record

ArticleJournal of lipid research2008

Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats.

U Singh, M R Dasu, P G Yancey, A Afify, S Devaraj, I Jialal

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 121 citations in OpenAlex.

  1. Pooled it
  2. Multiple functions of policosanol in elderly patients with dyslipidemia.The Journal of international medical research · 2020
    Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

U SinghDepartment of Pathology and Laboratory Medicine, University of California Davis Medical Center, Sacramento, CA, USA.
M R Dasu
P G Yancey
A Afify
S Devaraj
I Jialal
University of California Davis Medical Center · USVanderbilt University · US

Funding

CRP, Diabetes, AtherothrombosisR01HL074360 · NHLBI · UNIVERSITY OF CALIFORNIA DAVIS · PI JIALAL, ISHWARLAL · 2004 to 2010
$2.3M
NHLBI NIH HHS R01 HL-074360NHLBI NIH HHS R01 HL074360
6 · The paper itself

Abstract

C-reactive protein (CRP) is present in the atherosclerotic plaques and appears to promote atherogenesis. Intraplaque CRP colocalizes with oxidized low density lipoprotein (OxLDL) and macrophages in human atherosclerotic lesions. Matrix metalloproteinase-9 (MMP-9) has been implicated in plaque rupture. CRP promotes OxLDL uptake and MMP induction in vitro; however, these have not been investigated in vivo. We examined the effect of CRP on OxLDL uptake and MMP-9 production in vivo in Wistar rats. CRP significantly increased OxLDL uptake in the peritoneal and sterile pouch macrophages compared with human serum albumin (huSA). CRP also significantly increased intracellular cholesteryl ester accumulation compared with huSA. The increased uptake of OxLDL by CRP was inhibited by pretreatment with antibodies to CD32, CD64, CD36, and fucoidin, suggesting uptake by both scavenger receptors and Fc-gamma receptors. Furthermore, CRP treatment increased MMP-9 activity in macrophages compared with huSA, which was abrogated by inhibitors to p38 mitogen-activated protein kinase, extracellular signal-regulated kinase (ERK), and nuclear factor (NF)-kappaB but not Jun N-terminal kinase (JNK) before human CRP treatment. Because OxLDL uptake by macrophages contributes to foam cell formation and MMP release contributes to plaque instability, this study provides novel in vivo evidence for the role of CRP in atherosclerosis.

Indexed as

AnimalsBiological TransportC-Reactive ProteinHumansInflammationKineticsLipoproteins, LDLMacrophagesMaleMatrix Metalloproteinase 3Matrix Metalloproteinase 9RatsRats, WistarReceptors, LDLTissue Inhibitor of Metalloproteinase-1C-Reactive ProteinLipoproteins, LDLMatrix Metalloproteinase 3Matrix Metalloproteinase 9oxidized low density lipoproteinReceptors, LDLTissue Inhibitor of Metalloproteinase-1

Identifiers

PMID18245817
PMCPMC2311439
OpenAlexW2056127736

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.